Publication | Closed Access

Preclinical activity of trans-indazolium [tetrachlorobisindazoleruthenate(III)] (NSC 666158; IndCR; KP 1019) against tumour colony-forming units and haematopoietic progenitor cells

Medicinal ChemistryOncologyOncogenic AgentPreclinical ActivityMedicineNsc 666158Tumour Colony-forming UnitsCell BiologyAnti-cancer AgentCancer BiologyRadiation OncologyCancer ResearchTumor Biology